Viruses act like self-packing suitcases
17th October 2012
Faculty researchers have identified a crucial stage in the lifecycle of simple viruses like polio and the common cold that could open a new front in the war on viral disease.
The team are the first to observe at a single-molecule level how the genetic material (genome) that forms the core of a single-strand RNA virus particle packs itself into its outer shell of proteins. Lead researcher Professor Peter Stockley said their results overturn accepted thinking about the process and could open a chink in the armour of a wide range of viruses.
"If we can target this process, it could lead to a completely new class of anti-virals that would be less likely to create resistant viruses than existing drugs, which tend to target individual proteins," Professor Stockley said.
A number of important viruses like the common cold and polio have RNA (ribonucleic acid) instead of DNA as their genetic material. The observations reveal that the viruses' RNA initially has a much greater volume than the virus particles created after they are packed inside their protein shell.
"We realised that the RNA genome must have to be intricately folded to fit into the final container, just like when you pack to go on holiday and need to fold your clothes to fit into the space in your suitcase," said co-author Dr Roman Tuma from the University of Leeds' Faculty of Biological Sciences.
When the team added proteins to the viral RNA they saw an immediate collapse in its volume.
"It seems that viral RNAs have evolved a self-folding mechanism that makes closing the 'viral suitcase' very efficient. It's as though 'the suitcase and the clothes' work together to close the lid and protect the content," Dr Tuma said.
"The viral RNAs, and only the viral RNAs, can do this trick of folding up to fit as soon as they see the 'suitcase' coming. That's the important thing. If we can interfere in that process we've got a completely novel drug target in the lifecycle of viruses," Professor Stockley said.
"At the moment there are relatively few antiviral drugs and they tend to target enzymes that the virus encodes in its genome. The problem is that the drugs target one enzyme initially and, within the year, scientists are identifying strains that have become resistant. Individual proteins are extremely susceptible to this mutation. A fundamental process like the one we're looking at opens the possibility of targeting the collective behaviour of essential molecules, which could be much less susceptible to developing resistance," explained Professor Stockley.
The same phenomenon is seen in both bacterial and plant viruses. "While we have not proved it yet, I would put money on animal viruses showing the same mechanism too," Professor Stockley added.
The team used sophisticated instrumentation custom built at the University that allowed them to make the first ever single-molecule measurements of viral assembly. This allowed researchers to observe individual viral particles one at a time. "The specific collapse, which can only be seen in such assays, was totally unexpected and overturns the current thinking about assembly," Professor Stockley said.
The team also includes PhD student Alexander Borodavka, whose Wellcome Trust studentship funded the new research. They have recently secured a grant from the Biotechnology and Biological Sciences Research Council (BBSRC) to extend their research.
"We're now perfectly positioned to pursue questions about how this mechanism works in other viruses and we're already thinking about ways to start designing new antiviral drugs that would target this newly recognised feature of viral lifecycles," Professor Stockley said.
The research is published in the Proceedings of the National Academy of Sciences (PNAS).
Last 3 months. View all
Vas Ponnambalam, Leverhulme Trust (1/09/2013), £245,031
Darren Tomlinson, Leverhulme Trust (1/09/2013), £5,645
Michelle Peckham, Gareth Howell, Roman Tuma, David Beech, Nigel Hooper, MRC (1/05/2013), £893,675
Sarah Calaghan, Derek Steele, BHF (1/05/2013), £208,005
Neil Messenger, EPSRC (1/04/2013), £618,675
Lars Jeuken, BBSRC (1/04/2013), £300,633
Ian Wood, Dunhill Medical Trust (1/04/2013), £113,705
Paul Millner, Wellcome Trust (1/04/2013), £40,000
Andrew Macdonald, Yorkshire Kidney Research Fund (1/04/2013), £39,886
Samit Chakrabarty, Royal Society (1/04/2013), £15,000
Sarah Zylinski, Royal Society (1/04/2013), £11,000
Urwin, Howard Atkinson, BBSRC (1/03/2013), £626,738
Charlotte Haigh, Wellcome Trust (1/03/2013), £50,000
Jim Deuchars, Leeds Teaching Hospitals Charitable Foundation (1/03/2013), £34,618
Carrie Ferguson, Wellcome Trust (1/03/2013), £27,700
Viewing last 3 months | View all items
New research looks at how the management of farms and agricultural landscapes impacts on both pollinators of crops and natural enemies of crop pests. more
A key building block in the virus, which causes birth defects and stillbirths in sheep, goats and cattle, could be targeted by anti-viral drugs. more
A faculty-led study, published in the journal Ecology Letters, overturns the common assumption that evolution only occurs gradually over hundreds or thousands of years. more
The University of Leeds is leading a £5.7 million, government-backed initiative to transform the way replacement joints and other medical implants are made. more